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Abstract Antibodies against Escherichia coli-expressed uncou-
pling protein-2 (UCP2) and uncoupling protein-3 (UCP3) were
raised by operating the blotted proteins into the spleen of
minipigs. The antisera reacted more intensively with the
recombinant UCP2 and UCP3 than with uncoupling protein-1
(UCP1) isolated from brown adipose tissue. Moreover, anti-
UCP2 and cross-reacting anti-UCP3 antibodies identified the
presence of the UCP2/3 antigen in isolated mitochondria from
rat heart, rat kidney, rat brain, rabbit epididymal white adipose
tissue, hamster brown adipose tissue, and rabbit skeletal muscle.
It has been concluded that UCP2 is expressed in these tissues
(UCP3 in skeletal muscle); however their existence in mitochon-
dria had not previously been demonstrated.
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1. Introduction
UCP2 was originally identi¢ed by means of mRNA detec-
tion and probes derived from EST libraries [1,2]. It appears to
be ubiquitously expressed in human and mouse tissues. UCP3
was identi¢ed in the EST library [3] and by RT-PCR [4] and is
predominately found in human skeletal muscle. Human UCP2
is 59% identical [1] and UCP3 is 57% identical [4] with UCP1
from brown adipose tissue mitochondria. The uncoupling
function of UCP2 and UCP3 was inferred largely from their
homology with UCP1. Recently, however, Jabufirek et al. [5]
have demonstrated that puri¢ed, expressed UCP2 and UCP3
are functional uncoupling proteins in that they catalyze fatty
acid-dependent proton £ux in liposomes.
UCP2 maps with the quantitative trait loci for obesity on
mouse chromosome 7 and the human insulin-dependent dia-
betes locus-4 on chromosome 11; consequently, it was pro-
posed that UCP2 is a thermogenic protein regulated by diet
[1,2]. Several ¢ndings support this view. Thus, starvation in-
creased UCP2 and UCP3 mRNA levels in humans [6] and
UCP2 in rats [7] ; UCP2 and UCP3 mRNA increased with
high-fat diet [8,9] ; and UCP2 mRNA increased 5-fold in
white fat of obese ob/ob and db/db mice [2]. Additional ¢nd-
ings implicate UCP2 as an e¡ector in leptin-regulated lipo-
stasis, in which steady release of leptin by adipocytes stimu-
lates UCP2 transcription via a family of leptin-OB receptors
[10^12]. UCP2 involvement has also been proposed for the
e¡ect of thyroid hormone on resting metabolic rate [13,14];
however, this role has also been proposed for UCP3, based on
its selectivity for skeletal muscle in humans [3,4,15]. The ex-
istence of UCP2 mRNA in spleen, macrophages, thymus,
bone marrow [1] and Kupfer cells [16] has led to the specula-
tion that UCP2 mediates the thermogenic response to in£am-
matory stimuli. Supporting evidence for a role in fever came
from the increase of UCP2 mRNA by lipopolysaccharide in
liver, muscle and WAT and by IL-1L and TNF in liver. More-
over, this mRNA response was prevented by the antipyretic,
indomethacin [17]. It has been proposed that UCP2 also pro-
vides a defense mechanism against generation of reactive oxy-
gen species [18].
These and numerous other studies have been based entirely
on detection of mRNA levels using Northern blot techniques.
It seemed important to establish that these proteins are syn-
thesized and targeted to mitochondria of the respective tis-
sues. Accordingly, we raised antibodies against pure UCP2
and UCP3 proteins that were expressed in E. coli. This paper
presents an initial immunological screening for UCPs in in-
tact, isolated mitochondria. The results con¢rm the existence
of UCP2/UCP3 in a wide variety of rat, rabbit, and hamster
tissues.
2. Materials and methods
Rat liver and rat kidney mitochondria were isolated from Whistar
rats using standard procedures. Isolation bu¡er contained 250 mM
sucrose, 10 mM Tris-MOPS, 0.1 mM Tris-EGTA, pH 7.4, and 0.5%
BSA, which was omitted from the ¢nal wash. Rat brain mitochondria
were isolated using Percoll density gradient centrifugation [19]. Rat
heart mitochondria were isolated using trypsin digestion in 180 mM
KCl, 5 mM Tris-Cl, 10 mM Tris-EDTA, pH 7.4, and di¡erential
centrifugation in 180 mM KCl, 5 mM Tris-Cl, pH 7.4, containing
0.5% BSA [20]. Rabbit skeletal muscle mitochondria were isolated
from M. £exor fasciilatae as described [21]. Epididymal WAT was
isolated from rabbit, and then the WAT mitochondria were isolated
as described [22].
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2.1. Expression of UCP2 and UCP3 in E. coli
Human UCP2 and human UCP3 open reading frames were ampli-
¢ed by PCR and inserted into the Ndel and Notl sites of the pET21a
vector (Novagen). From DNA sequencing, the constructs are pre-
dicted to encode proteins with an amino acid sequence identical to
the wild-type UCP2 or UCP3 proteins. Plasmids were transformed
into the bacterial strain BL21 (Novagen). Transformed cells were
grown at 30‡C to OD600 = 0.6 and then induced with 1 mM IPTG
at 30‡C for 6 h. Cells from a 700 ml culture were lysed in a French
Press in 20 ml lysis bu¡er (10 mM Tris pH 7, 1 mM EDTA, 1 mM
DTT); the lysate was centrifuged at 27 000Ug for 15 min; and the
pellet was resuspended in 20 ml lysis bu¡er and centrifuged at
1000Ug for 3 min. One ml aliquots of the supernatant were centri-
fuged at 14 000Ug for 15 min in a microfuge. The resulting pelleted
inclusion bodies were stored frozen at 370‡C.
2.2. Extraction of UCP2 and UCP3 from inclusion bodies
The pelleted inclusion bodies (about 3 mg of protein) were sus-
pended and washed two times in 10 mM Tris-Cl, 0.1 mM Tris-
EDTA, pH 7.0. The washed pellet was pre-solubilized by 1.5 ml of
5 mM TEA-TES, 30 mM TEA2SO4, 0.1 mM Tris-EDTA, pH 7.2,
containing 0.3% sodium lauroylsarcosinate (SLS). After centrifugation
at 14 000Ug for 2 min, the resulting pellet was solubilized in 0.75 ml
of 5 mM TEA-TES, 30 mM TEA2SO4, 0.1 mM Tris-EDTA, pH 7.2,
containing 1.67% SLS and 1% octylpentaoxyethylene. Prior to immu-
nization, the proteins were mixed with sample bu¡er, and PAGE and
Western blots were performed as described below. About 100 mg of
each protein was blotted onto nitrocellulose membranes and identi¢ed
on duplicates with anti-rat UCP1 antibodies (from Karl Freeman,
McMaster University, Hamilton, Ont., Canada), alkaline phospha-
tase-conjugated anti-rat IgG secondary antibodies, and BCIP/NBT
tablets (Sigma).
2.3. Immunization
Healthy, 2 month old minipigs (two for each protein) were anes-
thetized with halothane, and the operative ¢eld was disinfected and
depilated under sterile conditions. Laparotomy was performed in the
left lateral mid-abdomen, and the spleen was elevated through the
incision. A triangular piece of the membrane with antigen was in-
serted inside the spleen sheath so that the antigen was in direct con-
tact with spleen tissue. The spleen was sutured and restored to the
abdominal cavity, and the laparotomy was closed and disinfected.
Animals received postoperative antibiotics for 6 days, and sutures
were removed on the 8th day. Two of the immunized animals were
re-operated after 3 weeks to receive an antigen booster. After another
3 weeks, the pigs were bled under general halothane anesthesia by
cannulation of the vena carotida externa. Sera were collected and
stored at 380‡C.
2.4. Western blots
Proteins were separated on Laemmli SDS-PAGE gels with 12%
acrylamide, using either a minigel Mighty Small II (Hoefer) or 15
cm gels on a Protean IIxi (Bio-Rad). Kaleidoscop and prestained
Mr standards (both Bio-Rad) were run on each gel. Proteins were
transferred to nitrocellulose membranes either using a tank blotter
TE22 (Hoefer, CA, USA, 120 mAî , 1 h) or in a semidry blotter (E
and K Scienti¢c Products Inc., with 0.8 mAî per 1 cm2 for 1 h). The
transfer bu¡er contained 50 mM Tris-Cl, 400 mM glycine, 0.35 mM
SDS, 20% methanol pH 8.3. After transfer, nitrocellulose sheets were
blocked overnight by 5% dry fat-free milk in a washing bu¡er, con-
taining 20 mM Tris-Cl, 500 mM NaCl, 0.05% Tween 20, pH 7.5.
Immunological detection was performed using anti-UCP2 or anti-
UCP3 immune sera as the primary antibodies, diluted 500 times for
sera from twice-operated pigs, or 10 to 100 times for once-operated
pigs. Antisera were incubated with antigen in washing bu¡er contain-
ing 2^5% dry fat-free milk for 1 h, followed by three 10 min incuba-
tions in washing bu¡er containing 2^5% dry fat-free milk. Detection
was achieved using anti-pig IgG (whole molecule) antibodies conju-
gated with alkaline phosphatase (Sigma), diluted 20 000 times in wash-
ing bu¡er, incubated for 1 h, washed three times in washing bu¡er,
and developed using BCIP/NBT tablets (Sigma). Western blots were
photographed using a Canon Power Shot Pro70 digital camera.
MALDI-MS was performed on a Bruker-Franzen BIFLEX instru-
ment after in-gel cleavage by endoproteinase Lys-C.
3. Results
3.1. Selectivities of anti-UCP antibodies
Fig. 1A contains representative Western blots of each of the
UCPs reacted with each of the three antibodies. The reaction
of anti-rat UCP1 antibodies with UCP2 and UCP3 is too
weak to see in the blot, illustrating the di⁄culty of tracking
these proteins with anti-UCP1 antisera. Thus, the broad sen-
sitivity of the anti-rat UCP1 antibodies is UCP1EUCP2 or
UCP3. The anti-UCP2 antibodies reacted in the order UC-
P2sUCP3EUCP1, and the anti-UCP3 antibodies reacted in
the order UCP3WUCP2EUCP1. We were interested in
whether the new antibodies were selective relative to UCP1;
accordingly, the gels were loaded with roughly equal amounts
of UCP2 and UCP3 and a 5-fold excess of UCP1 (Fig. 1B).
On this basis, we conclude that anti-UCP2 and UCP3 anti-
bodies cross-react with each other, but react very poorly with
UCP1. The Western blots shown are representative of 10 or
more experiments with each combination.
Fig. 1. A: Immunoreaction of anti-UCP1, anti-UCP2 and anti-UCP3 antibodies with UCP proteins. The upper row of labels designates the
antisera or antibodies used in the Western blots. The second row of labels identi¢es the antigens. Blots were developed as described in Section
2. Molecular mass (Mr) in kDa is based on the positions of Kaleidoscop standards (Bio-Rad). These results are representative of 10 or more
blots with each antibody/antigen combination. B: Typical migration of UCP1, UCP2 and UCP3 on PAGE. A gel run parallel to the Western
blots is shown after silver staining and digitalization by an electronic camera. Molecular mass (Mr) in kDa is based on the positions of Kalei-
doscop and low Mr standards (Bio-Rad).
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UCP2 and UCP3 migrate at 33^35 kDa. The other bands
visible in the Western blot were not visible in Coomassie-blue
stained gels and most likely arose from the presence of anti-E.
coli protein immunoglobins in the sera. To establish the cor-
rect identi¢cation, the putative UCP bands (marked by the
arrow in Fig. 1A) were identi¢ed by MALDI-MS to be
UCP2 (by 32.7% coverage of its identical sequence) or
UCP3 (by 40.7% coverage of its identical sequence).
3.2. Existence of UCP2/3 antigen in isolated mitochondria
Fig. 2 contains Western blots of mitochondria isolated from
various tissues and stained with anti-UCP3 antibodies, which
recognize both UCP2 and UCP3 (Fig. 1A). Mitochondria
from rat heart, rat kidney, rat brain, hamster BAT, rat epi-
didymal WAT, and rabbit skeletal muscle contained readily
detectable amounts of UCP2/3. The Western blots shown are
representative of three to ¢ve experiments with each tissue.
4. Discussion
Previous evidence for the existence of UCP2 and UCP3
proteins in mitochondria was largely inferred from mRNA
levels [1^4,6^11,13^17,23^27]. Because the postranslational
fate of the proteins was unknown, it remained to be estab-
lished that they were synthesized and localized to mitochon-
dria. Our results now con¢rm the existence of UCP2/3 protein
in mitochondria of heart, skeletal muscle, kidney, brain, WAT
and BAT. A previous report also identi¢ed UCP2 antigen in
WAT [12]; however, no documentation of the antibodies was
provided. Antibodies against a conserved peptide sequence in
murine and human UCP2 were reported to detect UCP2 in
liver of ob/ob mice [27] and in yeast expressing UCP2 [28].
Anti-UCP1 antibodies were used to detect UCP2 in Kupfer
cells [16] and fetal liver [29].
In view of their high level of sequence identities, it is not
surprising that the anti-UCP antibodies do not discriminate
well against each other. This may not detract seriously to their
usefulness in studying tissue distribution, because mRNA
studies indicate that UCP2 and UCP3 coexpress solely in
skeletal muscle in human tissues and in skeletal muscle and
BAT in rat tissues [3,4].
The work of many laboratories has led to considerable
progress in understanding control of expression of UCP2
and UCP3 (reviewed in [30^32]) and in understanding their
transport function on a biophysical level [5,33]. The major
challenges remain to deduce their physiological role in the
cell and the mechanisms used to regulate them.
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